SCHEINBERG DAVID A
Insider CIK 1250316 · SLS Director · CFRX Director · PGNX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLS SELLAS Life Sciences Group | A Award | 2026-01-07 | 2026-01-09 | 50,000 | — | $0 | 73,082 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2025-01-10 | 2025-01-14 | 18,500 | — | $0 | 18,500 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2025-01-10 | 2025-01-14 | 12,500 | — | $0 | 23,082 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2024-01-22 | 2024-01-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2024-01-22 | 2024-01-25 | 6,000 | — | $0 | 10,582 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2023-02-02 | 2023-02-03 | 9,500 | — | $0 | 9,500 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2023-02-02 | 2023-02-03 | 2,500 | — | $0 | 4,582 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2022-01-31 | 2022-02-01 | 7,125 | — | $0 | 7,125 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2022-01-31 | 2022-02-01 | 1,900 | — | $0 | 2,082 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2021-03-04 | 2021-03-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2020-03-12 | 2020-03-16 | 6,500 | — | $0 | 6,500 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2019-07-11 | 2019-07-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2019-07-01 | 2019-07-03 | 10,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2019-07-01 | 2019-07-03 | 10,000 | $5.33 | $53.3K | 56,185 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2019-03-14 | 2019-03-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2018-06-13 | 2018-06-14 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2018-06-12 | 2018-06-13 | 5,500 | — | $0 | 5,500 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award deriv | 2018-03-13 | 2018-03-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2017-12-29 | 2018-03-16 | 9,107 | — | $0 | 9,107 | SEC↗ |
| SLS SELLAS Life Sciences Group | A Award | 2017-12-29 | 2017-12-29 | 9,107 | — | $0 | 9,107 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2017-06-14 | 2017-06-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2016-06-08 | 2016-06-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2015-06-10 | 2015-06-11 | 20,000 | $6.72 | $134.4K | 20,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2014-06-17 | 2014-06-19 | 20,000 | $4.47 | $89.4K | 20,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2013-06-12 | 2013-06-20 | 20,000 | $4.76 | $95.2K | 20,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2013-03-22 | 2013-03-22 | 1,250 | $4.81 | $6.0K | 46,185 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2013-03-22 | 2013-03-22 | 1,250 | $2.47 | $3.1K | 47,435 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2013-03-21 | 2013-03-21 | 1,250 | $2.47 | $3.1K | 1,250 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $7.93 | $79.3K | 10,000 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2012-02-23 | 2012-02-27 | 1,250 | $10.00 | $12.5K | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise deriv | 2012-02-23 | 2012-02-27 | 1,250 | $6.90 | $8.6K | 1,250 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | S Sale | 2012-02-23 | 2012-02-27 | 1,250 | $10.00 | $12.5K | 46,185 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | M Exercise | 2012-02-23 | 2012-02-27 | 1,250 | $6.90 | $8.6K | 47,435 | SEC↗ |